Allworth Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14K Buy
3,997
+2,540
+174% +$10.4K ﹤0.01% 3246
2025
Q4
$4.91K Buy
1,457
+229
+19% +$595 ﹤0.01% 3723
2025
Q3
$1.61K Buy
1,228
+959
+357% +$993 ﹤0.01% 4101
2025
Q2
$193 Buy
+269
New +$211 ﹤0.01% 4320
2025
Q1
Sell
-666
Closed -$2.48K 4116
2024
Q4
$2.48K Sell
666
-4,619
-87% -$18.7K ﹤0.01% 3084
2024
Q3
$21.8K Buy
5,285
+4,431
+519% +$23.8K ﹤0.01% 1852
2024
Q2
$5.74K Buy
854
+841
+6,469% +$5.95K ﹤0.01% 2462
2024
Q1
$114 Sell
13
-162
-93% -$1.97K ﹤0.01% 3502
2023
Q4
$2K Buy
175
+159
+994% +$1.57K ﹤0.01% 2680
2023
Q3
$155 Sell
16
-1,286
-99% -$12.6K ﹤0.01% 3260
2023
Q2
$13.9K Buy
1,302
+15
+1% +$161 ﹤0.01% 1748
2023
Q1
$13.5K Buy
1,287
+123
+11% +$1.38K ﹤0.01% 1673
2022
Q4
$14.4K Sell
1,164
-118
-9% -$1.34K ﹤0.01% 1536
2022
Q3
$13K Buy
1,282
+1,256
+4,831% +$14.2K ﹤0.01% 1485
2022
Q2
$0 Hold
26
﹤0.01% 2587
2022
Q1
$0 Buy
26
+11
+73% +$126 ﹤0.01% 2242
2021
Q4
$0 Hold
15
﹤0.01% 2034
2021
Q3
$0 Buy
+15
New +$194 ﹤0.01% 1923

Other funds holding IRWD

Allworth Financial's IRWD Position: Q1 2026 in Review

Allworth Financial increased its Ironwood Pharmaceuticals (IRWD) stake by 174% in Q1 2026, buying an estimated $10.4K and bringing the position to 3,997 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3246.

Allworth Financial first reported a position in IRWD in Q3 2021 and has held it in 18 quarters since. The position peaked at $21.8K in Q3 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Allworth Financial held 3,997 shares of Ironwood Pharmaceuticals worth $14K as of Q1 2026.
  • Allworth Financial bought 2,540 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $10.4K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3246 holding.
  • Allworth Financial first reported a position in Ironwood Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
  • Allworth Financial's Ironwood Pharmaceuticals position peaked at $21.8K in Q3 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.